Internal Medicine, Endocrinology, Diabetes, & Metabolism · Yorktown, IN
NPI
1972709079
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1420 S Pilgrim Blvd
Yorktown, IN, 47396
Phone (765) 759-4068
Groups this clinician bills Medicare through
Medicare paid, 2024
$372K
25,146 services
Medicare patients, 2024
446
Average age 73
Drug cost, 2024
$1.9M
3,339 prescriptions
Company payments, 2025
$32.27
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Liliana P Garcia-Vargas was code J3111 (injection, romosozumab-aqqg, 1 mg), 17,010 times for 17 patients. In total Liliana P Garcia-Vargas billed 25,146 services in 23 codes, and Medicare paid $372K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-29.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 17,010 | 17 | $8.56 | $146K |
| J0897 Injection, denosumab, 1 mg | Office | 6,540 | 65 | $20.48 | $134K |
| 99214 Office E&M - Established | Office | 466 | 279 | $96.94 | $45K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 460 | 332 | $13.13 | $6,040 |
| 96372 Injection Administration | Office | 192 | 79 | $11.94 | $2,292 |
| 99205 Office E&M - New | Office | 97 | 97 | $154.54 | $15K |
| 99213 Office E&M - Established | Office | 94 | 81 | $69.93 | $6,574 |
| 95251 Test - Miscellaneous | Office | 76 | 46 | $26.88 | $2,043 |
| 83036 Blood Count | Office | 47 | 44 | $9.46 | $445 |
| 85018 Blood Count | Office | 43 | 41 | $2.32 | $99.76 |
| 99204 Office E&M - New | Office | 40 | 40 | $132.26 | $5,290 |
| 99215 Office E&M - Established | Office | 29 | 28 | $138.91 | $4,028 |
| 99442 Telephone Services | Office | 12 | 12 | $66.06 | $793 |
By year: 2022 $72K for 3,559 services; 2023 $246K for 13,611 services; 2024 $372K for 25,146 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 47 | 44 | $9.46 | $445 |
| 85018 Blood Count | 43 | 41 | $2.32 | $99.76 |
Medicare prescription drug claims, 2024
In 2024, the drug Liliana P Garcia-Vargas prescribed most often to Medicare patients was Levothyroxine Sodium, with 276 prescriptions and refills. In total Liliana P Garcia-Vargas wrote 3,339 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 276 | 564 | 63 | $8,739 |
| Ozempic Semaglutide | 246 | 416 | 56 | $387K |
| Alendronate Sodium Generic | 196 | 401 | 53 | $950 |
| Jardiance Empagliflozin | 168 | 349 | 45 | $198K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 146 | 386 | 52 | $18K |
| Forteo Teriparatide | 131 | 143 | 17 | $529K |
| Synthroid Levothyroxine Sodium | 92 | 201 | 24 | $8,173 |
| Metformin Hcl Generic | 92 | 247 | 28 | $889 |
| Metformin Hcl Er Metformin Hcl | 91 | 232 | 30 | $971 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 89 | 193 | 32 | $6,745 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 86 | 200 | 26 | $7,353 |
| Humalog Kwikpen U-100 Insulin Lispro | 72 | 124 | 24 | $21K |
| Glipizide Er Glipizide | 58 | 106 | 13 | $652 |
| Mounjaro Tirzepatide | 56 | 65 | Under 11 | $64K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 51 | 77 | 14 | $13K |
Brand drugs: 1,618 claims; generic drugs: 1,387 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Liliana P Garcia-Vargas $32.27 ($32.27 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $32.27.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $32.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.